Network pharmacology and multi-omics validation of the Jianpi-Yishen formula in the treatment of chronic kidney disease
ObjectiveChronic kidney disease (CKD) is a major global health problem. In clinical practice, the Chinese patent herbal medicine Jianpi-Yishen (JPYS) formula is commonly used to treat CKD. However, the molecular mechanisms by which JPYS targets and modulates the host immune response remain unclear.M...
Saved in:
Main Authors: | Yuyan Li, Yueming Luo, Yilan Hu, Siting Li, Guandong Li, Wanyangchuan Zhang, Xiufen Gu, Jianting Wang, Shunmin Li, Hong Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1512519/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Authenticity doubt on the Tomioka (Yishen Lun) manuscript: A discourse analysis
by: David T.W Tam
Published: (2025-02-01) -
Effects of Jianpi therapy for cancer-related fatigue:a meta-analysis of randomized controlled trials
by: Jiaxing Dai, et al.
Published: (2025-01-01) -
Jianpi Yiqi Busui prescription alleviates myasthenia gravis by regulating Th17 through the TAK1/P38 MAPK/eIF-4E signaling pathway
by: Zhuming Chen, et al.
Published: (2025-02-01) -
Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis
by: Xiaohui Meng, et al.
Published: (2025-01-01) -
Metabolomics, network pharmacology, and microbiome analyses uncover the mechanisms of the Chinese herbal formula for the improvement of meat quality in spent hens
by: Zhihua Li, et al.
Published: (2025-02-01)